SCHEMBL6426161

SCHEMBL6426161

O=C(Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2n1)c1ccco1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.54
ADORA2A P29274 1/20 0.54
ADORA2B P29275 1/20 0.54
ADORA1 P30542 1/20 0.54
ITK Q08881 1/20 0.45
SMN1; SMN2 Q16637 7/20 0.45
MAPT P10636 5/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
HTT P42858 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
LMNA P02545 1/20 0.45
HTR1A P08908 1/20 0.44
HTR1D P28221 1/20 0.44
HTR1B P28222 1/20 0.44
HTR1F P30939 1/20 0.44
LRRK2 Q5S007 1/20 0.43
RAB9A P51151 8/20 0.43
NPC1 O15118 7/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6427806 0.85 NPC1 (0.48) ADORA3ADORA2AADORA2BADORA1ITK
SCHEMBL4136721 0.82 MAPK8 (0.50) ADORA3ADORA2AADORA2BADORA1ITK
SCHEMBL4329234 0.79 MAPT (0.44) ADORA3ADORA2AADORA2BADORA1ITK
SCHEMBL14074986 0.79 GSK3B (0.56) RAB9ANPC1MAPK8MAPK10MAPK14
SCHEMBL4340833 0.78 SMN1; SMN2 (0.47) ADORA3ADORA2AADORA2BADORA1ITK
SCHEMBL4335934 0.77 NPC1 (0.46) ADORA3ADORA2AADORA2BADORA1ITK
SCHEMBL4136194 0.75 TTK (0.49) SMN1; SMN2MAPTMEN1KMT2AHTT
SCHEMBL13927649 0.75 RAB9A (0.53) ADORA2AADORA1ITKSMN1; SMN2MAPT
SCHEMBL4343191 0.73 MAPK1 (0.52) ITKMAPTKMT2ARAB9ANPC1
SCHEMBL4153491 0.72 CA12 (0.49) KMT2AKDM4EMAPK8MAPK10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429609-B2 Pyrazole compound and medicinal composition containing the same EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-30 US disclosed
US-7429609-B2 Pyrazole compound and medicinal composition containing the same EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-30 US disclosed
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B ADORA3 2249/4885ADORA2A 2046/4885ADORA2B 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.